Farmers & Merchants Investments Inc’s Neurocrine Biosciences NBIX Stock Holding History

Farmers & Merchants Investments Inc’s Portfolio NBIX Stock Details NBIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$15.2K	Hold	90	–	–	﹤0.01%	675
2026 Q1	$11.9K	Hold	90	–	–	﹤0.01%	723
2025 Q4	$12.8K	Buy	90 +3	+3%	+$435	﹤0.01%	670
2025 Q3	$12.2K	Buy	87 +4	+5%	+$542	﹤0.01%	696
2025 Q2	$10.4K	Buy	83 +10	+14%	+$1.15K	﹤0.01%	710
2025 Q1	$8.07K	Buy	73 +32	+78%	+$4.05K	﹤0.01%	743
2024 Q4	$5.6K	Hold	41	–	–	﹤0.01%	788
2024 Q3	$4.72K	Hold	41	–	–	﹤0.01%	832
2024 Q2	$5.64K	Hold	41	–	–	﹤0.01%	765
2024 Q1	$5.66K	Hold	41	–	–	﹤0.01%	730
2023 Q4	$5.4K	Hold	41	–	–	﹤0.01%	739
2023 Q3	$4.61K	Hold	41	–	–	﹤0.01%	748
2023 Q2	$3.87K	Hold	41	–	–	﹤0.01%	810
2023 Q1	$4.15K	Hold	41	–	–	﹤0.01%	760
2022 Q4	$4.9K	Hold	41	–	–	﹤0.01%	770
2022 Q3	$4K	Sell	41 -31	-43%	-$3.15K	﹤0.01%	792
2022 Q2	$7K	Hold	72	–	–	﹤0.01%	804
2022 Q1	$7K	Hold	72	–	–	﹤0.01%	837
2021 Q4	$6K	Hold	72	–	–	﹤0.01%	872
2021 Q3	$7K	Hold	72	–	–	﹤0.01%	809
2021 Q2	$7K	Hold	72	–	–	﹤0.01%	735
2021 Q1	$7K	Hold	72	–	–	﹤0.01%	711
2020 Q4	$7K	Hold	72	–	–	﹤0.01%	701
2020 Q3	$7K	Buy	+72	New	+$8.33K	﹤0.01%	651

Other funds holding NBIX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

IEQ Capital Foster City, California $21.7B AUM 77.3% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

Farmers & Merchants Investments Inc's NBIX Position: Q2 2026 in Review

Farmers & Merchants Investments Inc held its Neurocrine Biosciences (NBIX) position steady in Q2 2026 at 90 shares worth $15.2K. The position accounts for ﹤0.01% of the portfolio, ranked #675.

Farmers & Merchants Investments Inc first reported a position in NBIX in Q3 2020 and has held it in 24 quarters since. 490 funds tracked by Wall St. Rank hold NBIX as of Q2 2026.

Farmers & Merchants Investments Inc held 90 shares of Neurocrine Biosciences worth $15.2K as of Q2 2026.
Farmers & Merchants Investments Inc left its Neurocrine Biosciences share count unchanged in Q2 2026.
Neurocrine Biosciences made up ﹤0.01% of Farmers & Merchants Investments Inc's portfolio in Q2 2026, its #675 holding.
Farmers & Merchants Investments Inc first reported a position in Neurocrine Biosciences in Q3 2020 and has held it in 24 quarters since.
490 funds tracked by Wall St. Rank held Neurocrine Biosciences as of Q2 2026.

Based on Farmers & Merchants Investments Inc's 13F filing for Q2 2026, filed 20 Jul 2026.